Navegando por Assunto "Brosimum acutifolium"

Agora exibindo 1 - 3 de 3

Acesso aberto (Open Access)
Atividade antiproliferativa e antineoplásica de flavonóides da espécie Brosimum acutifolium em modelo de glioblastoma in vitro
(Universidade Federal do Pará, 2013-05-24) MAUÉS, Luis Antônio Loureiro; NASCIMENTO, José Luiz Martins do; http://lattes.cnpq.br/7216249286784978
Among the tumors that affect the nervous system, glioblastoma multiforme (GBM) is notable by its high degree of aggressiveness and poor prognosis, with an average survival of 15 months from diagnosis. The present study aimed to investigate the antiproliferative and antineoplastic activity of four flavonoids isolated from species Brosimum acutifolium (Huber). two flavans: 4'-hydroxy-7,8-(2",2"-dimethylpyran)-flavan (BAS-1) and 7,4'-dihydroxy-8-(3,3-dimethylallyl)-flavan (BAS-4), and two chalcones: 4,2'-dihydroxy-3',4'-(2",2"-dimetilpirano)-chalcone (BAS-6) and 4,2',4'-trihydroxy-3'-(3,3-dimethylallyl)-chalcone (BAS-7), tested on rat C6 glioblastoma in vitro. Our results showed good cytotoxic activity for flavans (BAS-1, -4) and the chalcone BAS-7, with IC50 less than 100 μM in the MTT viability test, since the chalcone BAS-6, showed no cytotoxicity at the concentrations tested. These flavonoids showed less cytotoxity for non-neoplastic cell (glia), with higher degree of security for the BAS and BAS-4-7, once showed lower cytotoxic effect on non-neoplastic cell, and less hemolytic. Analysis of cell migration showed that treatment with BAS-1; -4 and -7 at low concentrations was effective in promoting the inhibition of cell migration. These three flavonoids were also very promising in inhibiting colony formation and growth, and promote cell cycle arrest with a substantial increase in population SubG0 for treatment with BAS-1 and -4 with 100 μM. The flavans BAS-1 and -4 also showed increased ability to promote losing in the integrity of the mitochondrial membrane potential (ΔΨm) and increased for staining with Annexin V, indicating that these drugs cause death by apoptosis. However the analysis by electron microscopy showed markedly the presence of autophagic vacuoles in the treatment with BAS-4 suggesting that the process of cell death occurs by apoptosis as well as autophagy. Based on these results it can be concluded that the flavonoids BAS-1, -4, and -7 have potential as an anticancer agent in the therapy of GBM and BAS-4 is the most promising of all.
Acesso aberto (Open Access)
Caracterização do mecanismo de ação antiinflamatória do flavonóide BAS1 isolado da planta Brosimum acutifolium
(Universidade Federal do Pará, 2011-08-02) MORAES, Waldiney Pires; SILVA, Anderson Manoel Herculano Oliveira da; DINIZ, Domingos Luiz Wanderley Picanço; http://lattes.cnpq.br/9601463988942971
Inflammation is the body's response to injury and danger. Even though it’s a body defensive mechanism, this response’s intensity and/ or persistency might be harmful for an individual. In such context, natural products are important sources of biologically active molecules, and they’re considered promising resources for the discovering of new drugs. Based on ethno pharmacological studies, BAS1 flavonoid (4'-hydroxy, 7, 8 - (2'', 2''-dimethyl-pyran)-flavan), which hasn’t been described by literature yet, was isolated from the Brosimum acutifolium plant, popularly known as "mururé da terra-firme." Facing this, the present study aimed at characterizing the anti-inflammatory mechanism of action of BAS1 flavonoid in stimulated murine macrophages. Macrophages were activated with LPS and IFN-γ, cell viability was evaluated by the MTT, levels of inflammatory mediators were determined by ELISA (TNF-α, PGE2, IL-10) through Griess reaction (NO) and protein expression by Western blotting. The results demonstrate that BAS1 only has cyclotoxic effects at high concentrations (100 μM) inhibited NO production (95%), negatively regulated the expression of NOS-2, reduced the TNF-α production (39%) and PGE2 (57%), but didn’t with IL-10 in activated macrophages. Thus, demonstrating the pharmacological effect of BAS1 flavonoid, as well as supporting the usage of the Brosimum acutifolium plant as an anti-inflammatory in our region was an important contribution from this study. Furthermore, the production of this plant’s extract could provide the local population with an effective and affordable anti-inflammatory. The present work may also contribute to the establishment of a new classification of anti-inflammatory agents, based on natural flavonoids, such as BAS1.
Acesso aberto (Open Access)
Efeito protetor da flavana extraída da espécie Brosimum acutifolium contra danos causados por hipóxia em células retinianas: um estudo in vitro
(Universidade Federal do Pará, 2014-06-14) FONSECA, Susanne Suely Santos da; BAHIA, Carlomagno Pacheco; http://lattes.cnpq.br/0910507988777644; PEREIRA JÚNIOR, Antônio; http://lattes.cnpq.br/1402289786010170
Ischemic stroke causes neuronal death due to excitotocity and oxidative stress. In this work, we investigate the neuroprotective effect of an amazon plant Brosimum acutifolium which is rich in flavanas with antioxidant potential, such as 4',7-dihydroxy-8-(3,3-dimethylallyl) flavana (brosimin b) (Bb), in a experimental model hypoxia in vitro. Neuroprotective effect of Bb was evaluated using cell cultures obtained from chick embryo retinas submitted to hypoxy by deprivation of oxygen and glucose. The antioxidant power of Bb was evaluated by kidnapping of 2,2-diphenyl-1-picryl-hydrazyl (DPPH) molecules. The neuroprotective activity was evaluated through the effects under cell viability, oxidative and antioxidative profile after 3, 6 and 24 hours after hypoxia trough oxygen reactive elements (O2-) analysis and endogenous antioxidant activity power of the catalase enzyme, respectively. We demonstrate that in vitro hypoxia causes time-dependent decreasing of cell viability due to the excessive production of O2-. On the other hands, the Bb treatment (10 μM) significantly preserved the cellular viability after 3 and 6 hours of in vitro hypoxia. This effect contributed to decrease the oxidative stress generated by productions of O2- during the 3 initial hours of hypoxia and also induced the increasing in the power activity of catalase enzyme in all the tested times. Thus, we show that Bb treatment has an antioxidant and neuroprotector effects due to contribute with antioxidant response during the neural hypoxia-induced oxidative stresse in vitro. These results suggest the use of Bb as a potential drug for Ischemic stroke treatment in vivo.